Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Treasury Shares (2023 - 2025)

Zenas BioPharma (ZBIO) has 3 years of Treasury Shares data on record, last reported at $525350.0 in Q3 2025.

  • For Q3 2025, Treasury Shares changed N/A year-over-year to $525350.0; the TTM value through Sep 2025 reached $525350.0, changed N/A, while the annual FY2024 figure was $21172.0, 22.16% down from the prior year.
  • Treasury Shares reached $525350.0 in Q3 2025 per ZBIO's latest filing, up from $511100.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $525350.0 in Q3 2025 and bottomed at $21172.0 in Q1 2024.
  • Average Treasury Shares over 3 years is $221198.8, with a median of $27200.0 recorded in 2023.
  • The widest YoY moves for Treasury Shares: up 22.16% in 2024, down 22.16% in 2024.
  • A 3-year view of Treasury Shares shows it stood at $27200.0 in 2023, then dropped by 22.16% to $21172.0 in 2024, then soared by 2381.34% to $525350.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $525350.0 in Q3 2025, $511100.0 in Q2 2025, and $21172.0 in Q4 2024.